Optimal timing for hepatitis C therapy in US patients eligible for liver transplantation: a cost-effectiveness analysis-Reference-Cited by-同舟云学术

Optimal timing for hepatitis C therapy in US patients eligible for liver transplantation: a cost-effectiveness analysis

Published:2016-09-19 Issue:10 Volume:44 Page:1090-1101
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Njei B.¹²,McCarty T. R.³,Fortune B. E.¹,Lim J. K.¹

Affiliation:

1. Section of Digestive Diseases; Yale University School of Medicine; New Haven CT USA

2. Investigative Medicine Program; Yale Center of Clinical Investigation; New Haven CT USA

3. Department of Internal Medicine; Yale University School of Medicine; New Haven CT USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.13798/fullpdf

Reference58 articles.

1. Viral Hepatitis - Statistics & Survelliance CDC - Centers for Disease Control and Prevention http://www.cdc.gov/hepatitis/statistics/incidencearchive.htm

2. The burden of hepatitis C to the United States medicare system in 2009: descriptive and economic characteristics;Rein;Hepatology,2016

3. Review article: chronic hepatitis C - natural history and cofactors;Alberti;Aliment Pharmacol Ther,2005

4. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States;Wong;Gastroenterology,2015

5. Projecting future complications of chronic hepatitis C in the United States;Davis;Liver Transpl,2003

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost‐effectiveness of using hepatitis C viremic hearts for transplantation into HCV‐negative recipients;American Journal of Transplantation;2020-09-15

2. Management of Hepatitis C in Special Populations: HIV Coinfection, Renal Disease, and Decompensated Cirrhosis;Clinical Liver Disease;2020-07

3. Systematic review with meta-analysis: mortality in acute severe ulcerative colitis;Alimentary Pharmacology & Therapeutics;2019-12-10

4. Systematic review with meta-analysis: effectiveness of direct-acting antiviral treatment for hepatitis C in patients with hepatocellular carcinoma;Alimentary Pharmacology & Therapeutics;2019-12-06

5. Regional and Rural-Urban Differences in the Use of Direct-acting Antiviral Agents for Hepatitis C Virus;Medical Care;2019-04